The RBC membrane-coated nanoparticles (RBC@Hb@GOx NPs) loaded with hemoglobin (Hb) and glucose oxidase (GOx) were developed for treating glioblastoma (Figure 8A,B) [122]. The gene discussed is GSTM1; the disease is glioblastoma.